Foundation Pharmacy News Today

In youre a formula retail location there are rules around that those rules were put in place to protect the citizens. Thank you any Public Comment on that item . Seeing none, then we will take rebuttal starting with the permit holders. Thank you. Ryan patterson for the permit holder. I first want to clarify the question before the board is whether the Zoning Administrator erred or its not whether the permit was issued in error or the rules be changed. Its a clear question. If the Zoning Administ...

Checking account is the same and corporation is the same those things would have stayed the same regardless of the name change that is at the physical facility they represented theyll operate as the castro pharmacy. Not separate this is. Yes castro pharmacy we didnt see castro represented by the h s fireman or pharmacy they were going to operate under the castro pharmacy no representation made theyd operate under an umbrella or h f and identify with them and in the previous hearing there was con...

For an intake with the budget analyst next week. Does that 10 million include equipment as well . Yes. Okay. The last time we had a hearing i vaguely remember the number being over that amount. You had mentioned a specific number closer to 12 . I dont remember the exact dollars. Its was closer to 12 and and we came down to 10. Any money is great. What we are asking for is a step to getting back to that 80 percent which is what weve always advocated for. I might be getting ahead, the second part ...

Unfortunately its not accessible to in patients that we have in our local hospitals as well as our jails. I would also note that our city purchases many of our drugs for our inpatient populations and others with a contract through a Company Called innovation. Unfortunately the pricing for those particular drugs are covered by nondisclosure agreement and we dont have the ability to understand how those prices are set. The resolution is asking for four things. It asks the department of Public Heal...

The city and county of San Francisco. Some of the out patients are eligible to receive a low price negotiated by the federal government in the socalled 340 b program. Unfortunately its not accessible to in patients that we have in our local hospitals as well as our jails. I would also note that our city purchases many of our drugs for our inpatient populations and others with a contract through a Company Called innovation. Unfortunately the pricing for those particular drugs are covered by nondi...

This Program Allows us to get from others. The bottom line is we are paying through one part of our system for lower prices because they are negotiated through the federal government but two parts of our drugs we purchase dont have that same level of lower prices. Right. We use the organization to negotiate prices for the groups and it only applies to outpatient. On the drug purchasing that we do through innovation, my understanding is that the city and you are under agreement not to discuss the...

As well as our jails. I would also note that our city purchases many of our drugs for our inpatient populations and others with a contract through a Company Called innovation. Unfortunately the pricing for those particular drugs are covered by nondisclosure agreement and we dont have the ability to understand how those prices are set. The resolution is asking for four things. It asks the department of Public Health to use consumer websites to provide comparisons for drugs in San Francisco and as...

Going to our schools and making our neighborhood safe. But unfortunately even our residents that have good coverage are spending this money on medications. There are a lot of complicated issues that under lie why drug pricing is so high. There are a couple things that i would like to note that i have certainly explored with city staff on this issue. We have very little transparency on the prices set not only with drugs but also prices paid by the city and county of San Francisco. Some of the out...

United health uhcs terms and conditions. So it was a measure passed by the board. Obviously the board could revisit that language. I think as dave woods indicated on behalf of dph that if certain pieces and information are made public, we definitely would lose our ability to leverage better prices. Even prime vendors would be reluctant to act on our behalf because of another locality could point to San Francisco as being able to acquire a certain price and a certain drug and manufacturers would ...

More patients who retransitioned to originator infliximab after switching to a biosimilar discontinued infliximab than patients who remained on the biosimilar.